Artificial intelligence isn’t just capable of translating between existing languages—it can also create entirely new ones.

Solar energy is shaving thousands of dollars off council power bills in New Zealand's sunniest city - New Plymouth.

Inspired by diving birds, roboticists built the lightweight machines to move from water to air. The design may one day lead ...

As more and more data centers are proposed throughout the region and the state, the issues critics bring to the table are becoming fairly familiar — the amount of water used to cool the servers, air ...

Australia's water supplies are evaporating. According to researchers at Deakin University, the country's water infrastructure loses nearly 370 billion gallons every year due to evaporation, about ...

The upgrade components in Pragmata's Mass Production Array blend with the glowing panels of this city-like sector. With cars coming out of buildings and filament clusters blocking various paths, this ...

Greysun is the Lead Guides Editor at GameRant, where he oversees game help coverage for everything from the biggest AAA releases to standout indie and live-service titles. Professionally, Greysun has ...

The Mini-Cabins in the Mass Production Array in Pragmata are better hidden and better guarded than the ones you hunted previously. Here's where to find them. Finding all the Mini-Cabins in the Mass ...

Is consciousness something the brain produces, or is it woven into the fabric of reality itself? Renowned neuroscientist Christof Koch is challenging long-held scientific assumptions by confronting ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...